0001104659-22-001617.txt : 20220105
0001104659-22-001617.hdr.sgml : 20220105
20220105185008
ACCESSION NUMBER: 0001104659-22-001617
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220105
FILED AS OF DATE: 20220105
DATE AS OF CHANGE: 20220105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Beebe Katherine
CENTRAL INDEX KEY: 0001768867
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13341
FILM NUMBER: 22512966
MAIL ADDRESS:
STREET 1: 400 OYSTER POINT BLVD, SUITE 505
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TITAN PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000910267
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943171940
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 OYSTER POINT BLVD
STREET 2: SUITE 505
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 6502444990
MAIL ADDRESS:
STREET 1: 400 OYSTER POINT BLVD
STREET 2: SUITE 505
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
tm221868-2_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-01-05
0
0000910267
TITAN PHARMACEUTICALS INC
TTNP
0001768867
Beebe Katherine
400 OYSTER POINT BLVD., SUITE 505
SO. SAN FRANCISCO
CA
94080
1
1
0
0
President and COO
Option to Purchase Common Stock
1.18
2022-01-05
4
A
0
55000
0
A
2032-01-05
Common Stock
55000
55000
D
The options vest as to 27,500 shares on July 5, 2022 with the balance to vest in equal monthly installments over the 18 months thereafter.
/S/ Kate Beebe Devarney
2022-01-05